APPA
Sponsors
Akl Research & Development Limited, AKL Research and Development
Conditions
Knee osteoarthritisOsteoarthritis
Phase 2
A Trial of APPA in the Treatment of Knee Osteoarthritis
CompletedNCT04657926
Start: 2020-09-09End: 2021-10-01Updated: 2021-11-17
A placebo-controlled, double-blinded, randomized, dose-finding trial using a combination of apocynin and paeonol (APPA) for the treatment of knee osteoarthritis
CompletedCTIS2023-508791-11-00
Start: 2024-07-08End: 2025-06-23Target: 170Updated: 2025-01-24